Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

IMPORTANCE: Antiviral therapy cannot erase hepatocellular carcinoma (HCC) risk in patients with chronic hepatitis B, and it is not indicated for most hepatitis B virus (HBV) carriers. Another effective way of reducing HCC risk needs to be developed. Aspirin may prevent cancer development, but clinic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Intern Med
Главные авторы: Lee, Teng-Yu, Hsu, Yao-Chun, Tseng, Hsiao-Ching, Yu, Shi-Hang, Lin, Jaw-Town, Wu, Ming-Shiang, Wu, Chun-Ying
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2019
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503573/
https://ncbi.nlm.nih.gov/pubmed/30882847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.8342
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы